Somatic mosaicism in FSHD often goes undetected
- PMID: 15174019
- DOI: 10.1002/ana.20106
Somatic mosaicism in FSHD often goes undetected
Abstract
Autosomal dominant facioscapulohumeral muscular dystrophy (FSHD1A) is associated with contractions of the polymorphic D4Z4 repeat array on chromosome 4qter. The disease has a high frequency of new mutations of mitotic origin. Pulsed-field gel electrophoresis-based studies show that mitotic mutations leading to somatic mosaicism occur equally frequently in patients and parents. Nevertheless, somatic mosaicism in FSHD is mainly reported in asymptomatic parents by applying standard Southern analysis after linear gel electrophoresis. Explaining this apparent discrepancy, we here demonstrate that somatic mosaicism in FSHD patients goes largely undetected using the standard diagnostic technique, indicating that linear electrophoresis is unsuitable to identify mosaic patients. As a consequence, the phenotype of mosaic patient's offspring will be underestimated, whereas the recurrence risk in the symptomatic mosaic individuals will be overestimated. Moreover, somatic mosaicism may partly explain the observation of anticipation in de novo kindreds. Therefore, clinicians should always consider pulsed-field gel electrophoresis analysis in de novo FSHD families, in particular when the patient's phenotype is much milder than expected based on D4Z4 length proper.
Similar articles
-
Recurrent somatic mosaicism for D4Z4 contractions in a family with facioscapulohumeral muscular dystrophy.Neuromuscul Disord. 2005 Jul;15(7):471-5. doi: 10.1016/j.nmd.2005.03.005. Neuromuscul Disord. 2005. PMID: 15935668
-
De novo facioscapulohumeral muscular dystrophy: frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10.Am J Hum Genet. 2000 Jan;66(1):26-35. doi: 10.1086/302730. Am J Hum Genet. 2000. PMID: 10631134 Free PMC article.
-
Mechanism and timing of mitotic rearrangements in the subtelomeric D4Z4 repeat involved in facioscapulohumeral muscular dystrophy.Am J Hum Genet. 2004 Jul;75(1):44-53. doi: 10.1086/422175. Epub 2004 May 20. Am J Hum Genet. 2004. PMID: 15154112 Free PMC article.
-
Molecular diagnosis of facioscapulohumeral muscular dystrophy.Expert Rev Mol Diagn. 2002 Mar;2(2):160-71. doi: 10.1586/14737159.2.2.160. Expert Rev Mol Diagn. 2002. PMID: 11962336 Review.
-
The D4Z4 repeat-mediated pathogenesis of facioscapulohumeral muscular dystrophy.Am J Hum Genet. 2005 Mar;76(3):375-86. doi: 10.1086/428361. Epub 2005 Jan 24. Am J Hum Genet. 2005. PMID: 15674778 Free PMC article. Review. No abstract available.
Cited by
-
Genetic counseling and testing for FSHD (facioscapulohumeral muscular dystrophy) in the Israeli population.J Genet Couns. 2012 Aug;21(4):557-63. doi: 10.1007/s10897-011-9422-5. Epub 2011 Nov 23. J Genet Couns. 2012. PMID: 22109111
-
Hybridization analysis of D4Z4 repeat arrays linked to FSHD.Chromosoma. 2007 Apr;116(2):107-16. doi: 10.1007/s00412-006-0080-6. Epub 2006 Nov 28. Chromosoma. 2007. PMID: 17131163 Free PMC article.
-
Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing.Clin Epigenetics. 2014 Oct 29;6(1):23. doi: 10.1186/1868-7083-6-23. eCollection 2014. Clin Epigenetics. 2014. PMID: 25400706 Free PMC article.
-
Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy in Patients Clinically Suspected of FSHD Using Optical Genome Mapping.Neurol Genet. 2023 Nov 22;9(6):e200107. doi: 10.1212/NXG.0000000000200107. eCollection 2023 Dec. Neurol Genet. 2023. PMID: 38021397 Free PMC article.
-
Therapeutic Approaches in Facioscapulohumeral Muscular Dystrophy.Trends Mol Med. 2021 Feb;27(2):123-137. doi: 10.1016/j.molmed.2020.09.008. Epub 2020 Oct 19. Trends Mol Med. 2021. PMID: 33092966 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials